Life Science & Health Care
| Rank | Name | Agg. Deals Value | Clients Dimension | N. of Transactions |  |
 |
 |
 |
 |
Last Quarter |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | DLA Piper | 700 | 6692 | 3 | 93% | 100% | 100% | 96% | 96% |  |
| 2 | Chiomenti | 165 | 1758 | 3 | 92% | 96% | 96% | 96% | 96% | |
| 3 | CastaldiPartners Studio Legale | 95 | 3500 | 1 | 100% | 100% | 100% | 88% | 100% | |
| 4 | Freshfields Bruckhaus Deringer LLP | 75 | 25 | 1 | 88% | 100% | 94% | 96% | 94% | |
| 5 | ADVANT Nctm | 71 | 317 | 3 | 89% | 94% | 95% | 96% | 91% | |
| 6 | Bird & Bird | 45 | 75 | 1 | 91% | 91% | 89% | 89% | 89% |  |
| 7 | Gitti and Partners | 36 | 5013 | 2 | 95% | 96% | 95% | 95% | 95% | |
| 8 | Legance | 36 | 25 | 2 | 96% | 96% | 96% | 98% | 94% | |
| 9 | Nunziante Magrone | 35 | 25 | 1 | na | na | na | na | na |  |
| 10 | Corte - Food Law | 25 | 600 | 1 | na | na | na | na | na | |
| 11 | Simmons & Simmons | 25 | 150 | 1 | 93% | 93% | 89% | 98% | 86% | |
| 12 | Giovannelli e Associati Studio Legale | 25 | 25 | 1 | 100% | 100% | 100% | 100% | 75% | |
| 13 | Deloitte Tax & Legal | 15 | 150 | 1 | 96% | 100% | 100% | 96% | 100% | |
| 14 | Orrick Herrington & Sutcliffe LLP | 15 | 25 | 1 | 92% | 92% | 94% | 90% | 90% | |
| 15 | A&A Studio Legale | 6 | 138 | 2 | 88% | 88% | 88% | 88% | 88% | |
| 16 | RP Legal & Tax | 6 | 25 | 2 | 92% | 92% | 100% | 92% | 92% | |
| 17 | De Berti Jacchia Franchini Forlani | 5 | 10000 | 1 | 75% | 50% | 75% | 75% | 75% | |
| 18 | Trevisan & Cuonzo | 5 | 25 | 1 | na | na | na | na | na | |
| 19 | 3D Legal - d'Andria | 1 | 25 | 1 | na | na | na | na | na | |
| 20 | B – Società tra avvocati | 1 | 25 | 1 | na | na | na | na | na | |
| 21 | Best In Health | 1 | 25 | 1 | na | na | na | na | na | |
| 22 | Galletti Law | 1 | 25 | 1 | na | na | na | na | na | |
| 23 | Sani Zangrando Avvocati | 1 | 25 | 1 | na | na | na | na | na | |
| 24 | Stefanelli & Stefanelli Studio Legale | 1 | 25 | 1 | 75% | 75% | 75% | 100% | 50% | |
| Rank | Name | Agg. Deals Value | Clients Dimension | N. of Transactions | |
|
|
|
|
Last Quarter |